BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16088103)

  • 21. Transfer of cytokine-inducing bacterial products across hemodialyzer membranes in the presence of plasma or whole blood.
    Pereira BJ; Sundaram S; Barrett TW; Butt NK; Porat R; King AJ; Dinarello CA
    Clin Nephrol; 1996 Dec; 46(6):394-401. PubMed ID: 8982556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Kinetics of potassium transfer during hemodialysis].
    Bulliard C; Guignard JP; Ruiz J; Moret H; Fellay G
    Nephrologie; 2001; 22(1):15-9. PubMed ID: 11280036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
    Zehnder C; Gutzwiller JP; Renggli K
    Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of hollow-fiber dialyzer Plivadial Altra-Flux 140 on beta-2-microglobulin removal.
    Kes P; Zubcić A; Ratković-Gusić I; Prsa M; Sefer S
    Acta Med Croatica; 1997; 51(2):105-9. PubMed ID: 9204596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of different dialyzer membranes on cutaneous microcirculation during hemodialysis.
    Sato M; Morita H; Ema H; Yamaguchi S; Amano I
    Clin Nephrol; 2006 Dec; 66(6):426-32. PubMed ID: 17176914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of a polyacrylonitrile membrane and a membrane made of regenerated cellulose on the plasma concentrations of erythropoietin during hemodialysis.
    Opatrný K; Krouzecký A; Wirth J; Vít L; Eiselt J
    Artif Organs; 1998 Oct; 22(10):816-20. PubMed ID: 9790077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Boron diffusion across the dialysis membrane during hemodialysis.
    Usuda K; Kono K; Nishiura K; Miyata K; Nishiura H; Saito M; Goto E; Nakaya H
    Miner Electrolyte Metab; 1997; 23(2):100-4. PubMed ID: 9252976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms and kinetics of the synthesis and release of platelet-activating factor (PAF) by polyacrylonitrile membranes.
    Guastoni C; Tetta C; Hoenich NA; Gervasio R; Sereni L; Tessore E; Wratten ML; Civati G
    Clin Nephrol; 1996 Aug; 46(2):132-8. PubMed ID: 8869791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma levels of granulocyte elastase during hemodialysis: effects of different dialyzer membranes.
    Hörl WH; Steinhauer HB; Schollmeyer P
    Kidney Int; 1985 Nov; 28(5):791-6. PubMed ID: 3878906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Management of intraoperative anticoagulantless CHD with EVAL-dialyzer in four patients on maintenance hemodialysis].
    Wake M; Sanagawa Y; Tanaka Y
    Masui; 2002 Mar; 51(3):250-4. PubMed ID: 11925887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dialyzer performance in the clinic: comparison of six low-flux membranes.
    Kerr PG; Lo A; Chin Mm; Atkins RC
    Artif Organs; 1999 Sep; 23(9):817-21. PubMed ID: 10491028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics of phosphorus during hemodialysis and the calculation of its effective dialysis clearance.
    Schück O; Kaslikov J
    Clin Nephrol; 1997 Jun; 47(6):379-83. PubMed ID: 9202868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biocompatibility study based on differential sequestration kinetics of CD14+CD16+ blood monocyte subsets with different dialyzers.
    Griveas I; Visvardis G; Sakellariou G; Passadakis P; Thodis I; Vargemezis V; Pavlitou A; Fleva A
    Ren Fail; 2006; 28(6):493-9. PubMed ID: 16928619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of the type of membrane and heparin on serum lipid parameters during a dialysis session: a pilot study.
    Katopodis KP; Elisaf M; Balafa O; Nikolopoulos P; Bairaktari E; Katsaraki A; Siamopoulos KC
    Am J Nephrol; 2004; 24(5):469-73. PubMed ID: 15345918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adsorption of human recombinant erythropoietin on dialysis membranes in vitro.
    Mori H; Hiraoka K; Yorifuji R; Iwasaki T; Gomikawa S; Inagaki O; Inoue S; Takamitsu Y; Fujita Y
    Artif Organs; 1994 Oct; 18(10):725-8. PubMed ID: 7832652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
    Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
    J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New method for phosphate kinetics estimation during hemodialysis and on-line hemodiafiltration with endogenous reinfusion.
    Bolasco P; Ghezzi PM; Ferrara R; Cogoni G; Cadinu F; Casu D; Murtas S;
    Blood Purif; 2006; 24(3):301-8. PubMed ID: 16479093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Can we increase phosphate removal with conventional hemodialysis?].
    Albalate M; Fernández C; López MD; Gago C; Jarraiz A; Pulido A; González A; Santana H; Hernando P; Gazapo RM; Caramelo C
    Nefrologia; 2003; 23(6):520-7. PubMed ID: 15002787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Phosphate kinetics in patients on chronic hemodialysis].
    Okuda N; Kuno T; Nagura Y; Kanmatsuse K
    Nihon Jinzo Gakkai Shi; 2000 Jan; 42(1):30-5. PubMed ID: 10737011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficiency of three different hemodialysis membranes for plasma porphyrin removal.
    Fontanellas A; Herrero JA; Moran MJ; Coronel F; Sepulveda P; Barrientos A; Enriquez De Salamanca R
    Am J Kidney Dis; 1995 Jan; 25(1):30-3. PubMed ID: 7810529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.